Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 101-110 of 150 for

Edit search filters
  1. A Study to Evaluate the Safety, Tolerability and Microbiome Dynamics of SER-287 in Subjects with Ulcerative Colitis

    Rochester, MN

  2. A Study of the Effectiveness and Safety of Infliximab for Pediatric Patients with Inflammatory Bowel Disease

    Rochester, MN

  3. A Study to Evaluate Safety and Effectiveness of SHP647 as Induction Therapy in Participants with Moderate-to- Severe Crohn's Disease

    La Crosse, WI

  4. A Study of Immune Response to the Human Papillomavirus Vaccine in Young Women with Inflammatory Bowel Disease

    Rochester, MN

  5. A Study to Assess the Effectiveness and Safety of Risankizumab in Subjects with Ulcerative Colitis

    Rochester, MN

  6. Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis

    Rochester, MN

  7. Study to Validate a Novel PRO Tool and Imaging Index Items in Stricturing Crohn’s Disease

    Rochester, MN

  8. Patients with Inflammatory Bowel Disease (IBD) are at Increased Risk for Colorectal Cancer and Early Dysplasia

    Rochester, MN

  9. A Study to Evaluate the Patterns of Use of Biological Agents and Risk Factors for Discontinuation of Agents in Pediatric Crohn’s Disease (CD) and Ulcerative Colitis (UC) within the Pediatric Population

    Rochester, MN

  10. A Multicenter National Prospective Study of Pregnancy and Neonatal Outcomes in Women With Inflammatory Bowel Disease

    Rochester, MN

.

Mayo Clinic Footer